HCA Speaker SessionCancer Prevention with Professor Diana Sarfati - Te Aho o Te Kahu, Cancer Control Agency - Friday 12 November, 10.30- 11.30am
Health Coalition Aotearoa is hosting a Speaker Session exclusively for members, with Professor Diana Sarfati on pathways to prevent cancer.
Professor Sarfati will be covering the critical role of prevention as part of the cancer continuum, and as a powerful vehicle to reduce cancer burden and inequities. She will speak to the commercial determinants of cancer (alcohol, tobacco and unhealthy food) in the new health system structures. This seminar comes ahead of a cancer prevention report that will be released soon by Te Aho o Te Kahu, comparing evidence-based best practice across a range of risk factors, against existing cancer prevention efforts in Aotearoa.
Due to current Covid-19 restrictions, the session will be held online so all HCA members can participate, and is free to attend. HCA members can register for the session on this page, and will be emailed login details closer to to the time.
If you or your non-governmental organisation is has an interest in protecting public health from harmful products (alcohol, tobacco and unhealthy food), and no commercial conflicts of interest you can join HCA for no cost as an organisational member or an individual member to become eligible to attend member-only events.
Professor Diana Sarfati (MBChB, MPH, PhD, FNZCPHM) is National Director of Cancer Control and Chief Executive of Te Aho o Te Kahu, the Cancer Control Agency in New Zealand. Her role is to provide national leadership for, and oversight of cancer control, to provide policy advice to the Government, and to be accountable for ensuring progress towards the goals and outcomes in the New Zealand Cancer Action Plan.
Previously Diana was Head of the Department of Public Health and Director of the Cancer and Chronic Conditions (C3) research group at University of Otago, Wellington. She has led a large body of research relating to disparities in cancer outcomes. This work has resulted in the identification of key patient and health system factors that influence cancer survival. It has been used extensively by health policy makers, clinicians and other researchers to develop policies and practices that aim to reduce inequities in cancer outcomes
Diana has held a number of national and international roles. She is a current member of the International Advisory Committee to Lancet Oncology, the Advisory Committee to International Agency for Research on Cancer’s (IARC) Pacific cancer hub, IARC’s international expert group on social inequalities in cancer, the Academic Advisory Committee on the International Cancer Benchmarking Project, and she led a 2019 Lancet Oncology series on cancer in small island developing states. Diana is a former member of the NZ National Cancer Programme Leadership Board, the National Screening Advisory Group, the National Ethics Advisory Committee, the Bowel Cancer Taskforce and the National Bowel Cancer Screening Advisory Committee.
Registrations are open now – HCA members please use the form below